Navigation Links
Corporate Financial Planning Experts Gather at IE – Innovation Enterprise’s Financial Planning & Analysis for Pharma & Biotech Summit

Philadelphia, Pennsylvania (PRWEB) February 21, 2013

Within an ever-changing business environment there is an unquestionable need for organizations to become analytically competitive, innovative and agile. Building on IE. – Innovation Enterprise’s history of successful summits in this sector, the Financial Planning & Analysis for Pharma & Biotech event will bring together over 200+ senior finance leaders in a unique, collaborative environment.

With over 25 distinguished keynote speakers including: Director, Finance, Pfizer, Senior Director, Finance, Johnson & Johnson and Senior Director, Finance, Siemens Healthcare, this summit will provide attendees with an exclusive insight into processes at the most forward thinking organizations currently in the industry.

Commenting on the 2012 event a previous attendee noted: “This summit is unique in that it covers both financially and industry relevant topics. It’s an excellent opportunity to share and exchange information and knowledge with high level and international professionals.” From the 120 delegates at last year’s event, over 80% recommended the event to a colleague with a further 87% rating the summit as “good to excellent”.

Emma Flanagan, International Events Director at IE. – Innovation Enterprise: “From our research into the market it became clear that finance leaders are looking for a forum to exchange ideas with peers of a similar stature and experience. This summit was specifically designed for senior level attendees. It’s exclusive, CPE accredited and we’re really proud of the agenda that we’ve organized.”

Running concurrently to the Pharma & Biotech summit is the Financial Planning & Analysis in Healthcare Summit where speakers from companies such as the American Academy of Physician Assistants and DaVita will be congregating to discuss their challenges and best practices in a no holds barred environment.

For a complete list of speakers, agenda and registration details for the Financial Planning & Analysis for Pharma & Biotech Summit please visit:

About IE.: The Innovation Enterprise Ltd, a CFO Publishing company is an independent business-to-business multi-channel media brand focused on the information needs of Senior Finance, Operations, Planning, Strategy, Decision Support & Advanced Analytics executives. Products include IE.Summits, IE.Finance, IE.Analytics, IE.Operations, IE.Strategy, IE.Membership and IE.Insights. Whether it's delivered online, or in person, everything IE produces reflects the company's unshakeable belief in the power of information to spur innovation.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. China Cord Blood Corporation Announces Completion of Corporate Structure Consolidation
2. Novus Biologicals Hires David Eansor to Lead New Corporate-Development Effort
3. Amarantus Bioscience Launches Online Corporate Communication Channels
4. China Cord Blood Corporation to Further Consolidate its Corporate Structure
5. 2012 Battalia Winston Survey Finds Corporate Holiday Parties are Making a Comeback
6. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
7. CTI Appoints Monique Greer, Senior Vice President, Corporate Communications and Investor Relations
8. New "GMO Inside" Campaign Denounces Corporate Disinformation Campaign That Defeated Californias Prop 37
9. Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
10. BioLife Solutions Completes Corporate Facilities Expansion, Build-Out of Additional cGMP Clean Room Manufacturing Suite
11. Amarantus BioSciences Corporate Overview to be Webcast Live Today from OneMedForum 2012 Conference in NYC
Post Your Comments:
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
Breaking Biology Technology:
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the medical ... premium product recently added to the range of products distributed by Ampronix. ... ... ... Ampronix News ...
(Date:5/12/2016)... , May 12, 2016 , ... published the overview results from the Q1 wave of ... recent wave was consumers, receptivity to a program where ... with a health insurance company. "We were ... share," says Michael LaColla , CEO of Troubadour ...
Breaking Biology News(10 mins):